Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285587152> ?p ?o ?g. }
- W4285587152 abstract "Chemotherapy combined with or without targeted therapy is the fundamental treatment for metastatic colorectal cancer (mCRC). Due to the adverse effects of chemotherapeutic drugs and the biological characteristics of the tumor cells, it is difficult to make breakthroughs in traditional strategies. The immune checkpoint blockades (ICB) therapy has made significant progress in the treatment of advanced malignant tumors, and patients who benefit from this therapy may obtain a long-lasting response. Unfortunately, immunotherapy is only effective in a limited number of patients with microsatellite instability-high (MSI-H), and segment initial responders can subsequently develop acquired resistance. From September 4, 2014, the first anti-PD-1/PD-L1 drug Pembrolizumab was approved by the FDA for the second-line treatment of advanced malignant melanoma. Subsequently, it was approved for mCRC second-line treatment in 2017. Immunotherapy has rapidly developed in the past 7 years. The in-depth research of the ICB treatment indicated that the mechanism of colorectal cancer immune-resistance has become gradually clear, and new predictive biomarkers are constantly emerging. Clinical trials examining the effect of immune checkpoints are actively carried out, in order to produce long-lasting effects for mCRC patients. This review summarizes the treatment strategies for mCRC patients, discusses the mechanism and application of ICB in mCRC treatment, outlines the potential markers of the ICB efficacy, lists the key results of the clinical trials, and collects the recent basic research results, in order to provide a theoretical basis and practical direction for immunotherapy strategies." @default.
- W4285587152 created "2022-07-16" @default.
- W4285587152 creator A5004095985 @default.
- W4285587152 creator A5004536654 @default.
- W4285587152 creator A5025231990 @default.
- W4285587152 creator A5056062916 @default.
- W4285587152 creator A5075025996 @default.
- W4285587152 creator A5079481208 @default.
- W4285587152 creator A5085028455 @default.
- W4285587152 date "2022-07-16" @default.
- W4285587152 modified "2023-10-16" @default.
- W4285587152 title "Exploring immunotherapy in colorectal cancer" @default.
- W4285587152 cites W1564645839 @default.
- W4285587152 cites W1572267688 @default.
- W4285587152 cites W1910384556 @default.
- W4285587152 cites W1933761723 @default.
- W4285587152 cites W1934094702 @default.
- W4285587152 cites W1938515409 @default.
- W4285587152 cites W1940241680 @default.
- W4285587152 cites W1950829641 @default.
- W4285587152 cites W1960485012 @default.
- W4285587152 cites W1982488143 @default.
- W4285587152 cites W1984642649 @default.
- W4285587152 cites W1986937402 @default.
- W4285587152 cites W1992752083 @default.
- W4285587152 cites W2000100421 @default.
- W4285587152 cites W2002226820 @default.
- W4285587152 cites W2016983859 @default.
- W4285587152 cites W2029275361 @default.
- W4285587152 cites W2031572048 @default.
- W4285587152 cites W2040229544 @default.
- W4285587152 cites W2044643325 @default.
- W4285587152 cites W2044682579 @default.
- W4285587152 cites W2052228812 @default.
- W4285587152 cites W2053213954 @default.
- W4285587152 cites W2057023729 @default.
- W4285587152 cites W2059128083 @default.
- W4285587152 cites W2060469376 @default.
- W4285587152 cites W2079018735 @default.
- W4285587152 cites W2092976034 @default.
- W4285587152 cites W2094390470 @default.
- W4285587152 cites W2098005365 @default.
- W4285587152 cites W2099044540 @default.
- W4285587152 cites W2103959341 @default.
- W4285587152 cites W2104237716 @default.
- W4285587152 cites W2104347254 @default.
- W4285587152 cites W2104501624 @default.
- W4285587152 cites W2104885590 @default.
- W4285587152 cites W2107484016 @default.
- W4285587152 cites W2109715458 @default.
- W4285587152 cites W2111381709 @default.
- W4285587152 cites W2112565258 @default.
- W4285587152 cites W2123363005 @default.
- W4285587152 cites W2124499950 @default.
- W4285587152 cites W2127640925 @default.
- W4285587152 cites W2132105937 @default.
- W4285587152 cites W2133075384 @default.
- W4285587152 cites W2134232737 @default.
- W4285587152 cites W2140416445 @default.
- W4285587152 cites W2144026118 @default.
- W4285587152 cites W2145411470 @default.
- W4285587152 cites W2147958411 @default.
- W4285587152 cites W2154298769 @default.
- W4285587152 cites W2154546296 @default.
- W4285587152 cites W2156353875 @default.
- W4285587152 cites W2159064822 @default.
- W4285587152 cites W2164617114 @default.
- W4285587152 cites W2165456770 @default.
- W4285587152 cites W2185075416 @default.
- W4285587152 cites W2201379305 @default.
- W4285587152 cites W2214552500 @default.
- W4285587152 cites W2262414037 @default.
- W4285587152 cites W2273119405 @default.
- W4285587152 cites W2293531514 @default.
- W4285587152 cites W2299181842 @default.
- W4285587152 cites W2303158491 @default.
- W4285587152 cites W2318233342 @default.
- W4285587152 cites W2323356988 @default.
- W4285587152 cites W2329974159 @default.
- W4285587152 cites W2383119765 @default.
- W4285587152 cites W2414977199 @default.
- W4285587152 cites W2465860350 @default.
- W4285587152 cites W2470575266 @default.
- W4285587152 cites W2488353409 @default.
- W4285587152 cites W2514929667 @default.
- W4285587152 cites W2516749362 @default.
- W4285587152 cites W2522313999 @default.
- W4285587152 cites W2524088453 @default.
- W4285587152 cites W2526607882 @default.
- W4285587152 cites W2527905628 @default.
- W4285587152 cites W2530516001 @default.
- W4285587152 cites W2547310148 @default.
- W4285587152 cites W2557336488 @default.
- W4285587152 cites W2558219863 @default.
- W4285587152 cites W2560367415 @default.
- W4285587152 cites W2561459036 @default.
- W4285587152 cites W2567334173 @default.
- W4285587152 cites W2567564314 @default.
- W4285587152 cites W2572174216 @default.
- W4285587152 cites W2575095806 @default.